CD1d-restricted help to B cells by human invariant natural killer T lymphocytes

被引:198
|
作者
Galli, G
Nuti, S
Tavarini, S
Galli-Stampino, L
De Lalla, C
Casorati, G
Dellabona, P
Abrignani, S
机构
[1] IRIS, Res Ctr, Chiron Vaccines, I-53100 Siena, Italy
[2] Ist Sci San Raffaele, Canc Immunotherapy & Gene Therapy Program, I-20132 Milan, Italy
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 2003年 / 197卷 / 08期
关键词
autoreactivity; cytokine; a-galactosylceramide; antibodies; helper assay;
D O I
10.1084/jem.20021616
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Invariant natural killer T (NKT) cells are a highly conserved subset of T lymphocytes expressing a semi-invariant T cell receptor (TCR), which is restricted to CD1d and specific for the glycosphingolipid antigen alpha-galactosylceramide. Their ability to secrete a variety of cytokines, which in turn modulate the activation of cells of both innate and acquired immune responses, suggests that invariant NKT cells exert a regulatory role mainly via indirect mechanisms. A relevant question is whether invariant NKT cells can directly help B cells. We document here that human invariant NKT cells are as efficient as conventional CD4(+) Th0 lymphocytes in promoting proliferation of autologous memory and naive B lymphocytes in vitro, and in inducing immunoglobulin production. Help to B cells by invariant NKT cells is CD1d-dependent and delivered also in the absence of a-galactosylceramide, suggesting that NKT cells recognize an endogenous ligand presented by CD1d on B cells. The two major subsets of invariant NKT cells, CD4(+) and double negative (CD4(-)CD8(-)), express comparable levels of CD40 ligand and cytokines, but differ in helper functions. Indeed, both subsets induce similar levels of B cell proliferation, whereas CD4(+) NKT cells induce higher levels of immunoglobulin production. These results suggest a direct role for invariant NKT cells in regulating B lymphocyte proliferation and effector functions.
引用
收藏
页码:1051 / 1057
页数:7
相关论文
共 50 条
  • [1] Turned on by danger: activation of CD1d-restricted invariant natural killer T cells
    Lawson, Victoria
    IMMUNOLOGY, 2012, 137 (01) : 20 - 27
  • [2] Recognition of CD1d-restricted antigens by natural killer T cells
    Rossjohn, Jamie
    Pellicci, Daniel G.
    Patel, Onisha
    Gapin, Laurent
    Godfrey, Dale I.
    NATURE REVIEWS IMMUNOLOGY, 2012, 12 (12) : 845 - 857
  • [3] Recognition of CD1d-restricted antigens by natural killer T cells
    Jamie Rossjohn
    Daniel G. Pellicci
    Onisha Patel
    Laurent Gapin
    Dale I. Godfrey
    Nature Reviews Immunology, 2012, 12 : 845 - 857
  • [4] CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells
    Spada, FM
    Koezuka, Y
    Porcelli, SA
    JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08): : 1529 - 1534
  • [5] The immunoregulatory role of CD1d-restricted natural killer T cells in disease
    van der Vliet, HJJ
    Molling, JW
    von Blomberg, BME
    Nishi, N
    Kölgen, W
    van den Eertwegh, AJM
    Pinedo, HM
    Giaccone, G
    Scheper, RJ
    CLINICAL IMMUNOLOGY, 2004, 112 (01) : 8 - 23
  • [6] Regulation of immune responses by CD1d-restricted natural killer T cells
    Luc Van Kaer
    Immunologic Research, 2004, 30 : 139 - 153
  • [8] Lipid and glycolipid antigens of CD1d-restricted natural killer T cells
    Venkataswamy, Manjunatha M.
    Porcelli, Steven A.
    SEMINARS IN IMMUNOLOGY, 2010, 22 (02) : 68 - 78
  • [9] A Role for CD1d-restricted Invariant Natural Killer T Cells and Glycolipids in Alpha-Gal Allergy
    Iweala, Onyinye I.
    Savage, Paul B.
    Commins, Scott P.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB288 - AB288
  • [10] CD1d-restricted natural killer T cells: Roles in tumor immunosurveillance and tolerance
    Jerud, ES
    Bricard, G
    Porcelli, SA
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2006, 33 (01) : 18 - 36